4bѶ`)0!Q2v({tB`rX Lr&YTK ̻Ѕ3e ]2 WCԓ4]=d;ygC8W4 "1$ a" kCu+5$Ĩt`avԥ[:V>k*&S CWãP30s%a̯DU
s0l k<1 J8 N;l(F7h @ߧ9tk^^)<@MxOQHC/>m m^1eyʵ6jsҴh"\W R;փbt`t IsR&睇a NI@/LU?!-v#O`C˔V $m:m@T2k}jڄTK
n(Z6B foA 1v|; ٽ O M 5ߧmCi^ &M2{P8mܐ ~ n0,U S !7sQnf-!{PC?A47U#%J wm[ hfԡ)0DC)"6~D
(KxYmm¥Я1<6 ^e עa+c ,ז덟1BvX/٥,8e) و1
bHöxP9'C:[cx6XNs0ܺJ`K]vǽSɶi9\Ra R ՙ`U;rʽ 1L ī퍘`8ҍ BIeZ QE;3GЬkDO6ahw -F )(oHhFQy8鱘y&5*U
a`BJ]Z +)ǰc-Fל:H)Jk T ;i s٫@_ L&.'.Xj忧aá7&o-җUhVc)U1C,P]'vi:l{;a(@mc
_]ͷ1c1Kua퀴՛y)_NHF
j{ Aͷ$NMrް+[Q (K6j!9ն kW1_CD1lIo!F3wG ]A>Ż2-j5[UlX>KQ0 1^V- Jf;)p26;S]ưSa 9u]cxtfe5+C
2#5) 1S'۟3fP9 $@*m,Ms/Ϊak k aa( >C7v#>ٖ)!13G bu@"X F"⽎Sӑd-Up2&
ɴZcU09Sc0 CZץ<ۢá;UiWY L
/6FQZ #OKǼU Zy@ b*ӥQOMX0Z,(y[aVpUc0*Yc(m !; .ɬ>)S;v pI1ٰcQԢ0gLt 6%t.PW \
{^)Ka,|ۢyuk "q#0[ecR!Bm
^0\c5RQ^\07]^ma8ӿfWyCQ D .P0̼-R!du}^ _7cQa>aѳxuebhfM/$S
C:1|UN1| P7Yid!Jo|諌!550[5 /. jda| "}IjBx ^k7b֤1{%~IE ??ھ?z 3vT[0u 0|,U[chP
{zj ($C>FrsQN@̲Hß5zCxhb8q0
0l0[0Ҥ Hy%1!㥢1o$ˢӡ fS,ΜEo (1ףC^phVCCK` $E
endstream
endobj
36 0 obj
<>stream
h웋cƝE`@B" r-S+: /}uUVk|ni<].^M\iv_ HDi[=(D$"& b]M73#lMloBvWUUEQȒMaK6| 4W7ѳٷɰPC"-ۇ^*,ZC.Ueל xtAOc |jٜEðu:
b inH4)WCdJd1$ r%GZvuiŖf͌Ec[aܬCCc`8C:i5t4 9.jSV: Cv U.n hRpW0Rw׀!'W&n n~;gTl +0" ;`_,'&-!yCkYzǯ29~k0ll1lqJe: Gu4
/aNǢÓ^cVn#ڴ@]!c1
]7Y? WHJ^L&1nWӜ#8, z*6ms@R!M7l0ll0laVpnZub( Ձ0< rachPT_Cg ۩b)@:)qNb)\`'PfP&J9 {ȟ8S}vu Y_m0lcX4dQ;R*3wRQ\&ݍ0dq)irJ~ 㜬7
4CV+zPZZ1Nac
+a;Co`
c ю_i vnbo!a*i 71TLT C46` :D܍1tEjp24pT5en0ll{1lW M`eWܚLG#`(56`XCu,,.eA`X;?5t%{<C skYtU:̟vjVm0WEj$%-Ɛnae -c`X:vX sý7,ca']i@ll0,Ҕ:a9'` &Bͭ'_!m0lb~h t4(shY{ b+iڍ-Ɛ9 % 02qBPʼa ؔh1;\7S-adm7t`izv_'R` 9 yn NWP]C^F0C ϗJ-=vaS+mlK)LcHsC
chTkp-08
~ 7XRPnThVQFiƶ iT r# j0Մ6+b2 Eac[a8*b81') U9LNb wwhv5 if4]m(CRC e8̻v
l l0lbHݫ`xT/Fay q)<۳?|?&cM-0 IKL 44zlQUSahRbEParƶ ð"2wy._Is,&W1,p % o4$6D2I)81JkhRvŷnVdz{ o5U |^C˞0ovR&=ll0 z0|>XÂ)xG1-랡i zU46EZ$dC0<1^(
a5ϓ>St0pac Z)F
mZ2bTը-0q'Z)!6a0ԏY
CdaHÆƶCէ>?Ýq/umM}hR
o\a| 99?x;D a0ziXe] Ǥ1D~EeR17Må9WV^i\[Vٿ1!ah>ZE{ RYGL7?i [z)s!zDBRa{ ,gBfRU392J.`?Zz Ȥ:|}bC,#'8.Csi?3;u:MxZyK8+tRcO2 躇^e@9b82;TÔ#ķܹɣyA!-@Yе (&vY7]k˫g
- aGgy5 ͱ5eckc0Ź3^seaݭ.to+ex`ܳN ff ㏣0&vK;psg
KB(I
Һ7ռ CF5 1 U
tr `xwa| 3E dȉhU1̰95⹅
dIb$
^
zvyL!A:0dY9b5xy/ q8Յ>-8)"q ч ٵwI= Ϯ~
9 IӐRgh,{."%{m Ib^U ';)/7@ Qd3Ԥ2ß$OIt: vGJjDJ&};Cs @0*u\UA2yG&,-> Ywc(e4w9C_~#B;rr=fHn!z~ 器/Mh[ 6n Aj'PN0t "6a|}/O>xwbS ?HOH]O~B0mOe |4.QIny
@sԫpz1j%}ͨV:̴<
KSa)iY !#" -DŽDwö`>i?SfN9f2y$ e{oo ~8|æi|YGz > XEL#S)P CV&UȪW`"*0ds:P9a)»)̞8 &Vnm} }WשO$TÈWO)B x)/ZC?"f]b8ZikSa)VaAųˡ ZH<1d ~ Oy ?xHˏ>M&E,yCh9kp*ID.Q%05b3N W
!fIӍ" jû;\>. B|GxAS Ka YUko ݲ_vBB#R6X9o,X0\g`9ڨ2o9/me.e(/) " C[1жޱC |C
i=wr*49:eJubֳE%j|ijB +IWǞOk~4O`"!QH=Ď;? ^ r1Ԝe(7NQ` 9nR'U5&Z+-3HvG1LE XON
*N&S
k.!jNGxjg)Z g6UmrҨ@)6r3r$;B14#g=hI&B;!Y|1r;+c# C#"$Gd ^Y44U|a4G2[o>C K4lwT Eush$;tTJ[Ga' zP^)LsrgET~믿 M8D&!2[LZBMs33 ă9
5>!=5*0D~Prˬ +X֕1o!:Mi c5?=t=b:a8c{
I) ##])U !^z4R۷o= ,ufaARa?EƵ7Sh)k@`P>*ָA( c%)WGdžtSH}ft q۫9BmPW3 ,ɬ!#c/jc;t=b^nt+D 0.w£>A7PiV5n]v}@,kRR,S\ CPߖj Ƣߧ SG?ϟO'QGo!ˀI+ŭPCp5 秴 Z/km~.(~DX =pUJ^s{0,N0~U'Ί
?) %~ E 3Tyxk әa=c 1/ҔcswΝPi
rx`{M`?ApoC 8J=YC46 C0'lIJ#IJWs&[
i]lac\w[g4C9pBc_0Eԓbc IU3̪.}(_. 3 YN7_; Ű%[՜F+;CtJ2C`Ft)]+1Ccܹw#W?Q|;Oˁa'lr. 5(Cmp 7 D6ü6.!-iZp3Y-zB$p>/Sl"vD;q tWnJ>3-\B
i/ԝZȬg8ݻaZ oZKzbh>z低SĻ,R
C%uugFD:c(ת_G `ǙJi] *3xw2I ̱jE£a 4?prԕXMTЦ}hen"kE-CY]izC vUpl0- 'ZZH p
!2wέԁ;ԺN[Z\f wx])-CtDGfqXBBX&NfuzQ ]֖iˣ½M̛4HbÔU0>e Q2U~r;5EtV؉д Dɏ|YLfX$m/y
Ah10 CSxo}v$:ZBM4ÐZi&) 5QemCyhqQ0"0UB D_ËgIv"oCw3na~qWD2 ҖcXjBVmƐxilY"[Uh/SˏH0;uzjüCMĥEuw?m+L Zdq; ƿYX-B%z7s6^.P>Cwykj5F Uu L"Y 8(׀!pa:Q(;loe4PQ~(n̷B>Q< 1P&joKU6Z*Y@FzoͲ6 т(Uˤׅ KW6-T@G[,~hSm t@P0aiBh*l !M
56:8GuIq1B}5ysIvbhzR7PBqiIMʃg7_"-MDiG eh߁ȴ֯[bO(SMK'j̵(^HTaFf` (`#n6>CHB]f3Y~6cù |O|o/\D`=9 I5Iۦ0LC
kTTK`;rvNA̬nK WX02(
z ^>Mu@P *|= \Ә$@?S 1aaCdJ{j,ݮy$US̯~ ^2r:1nF;U4H`b-EiNM0dv[?m$NZ!{Faaq_ KojsVfh2,]3r!^c[JZDÇߕۭ 7
nlUΚk<`n!1x $ɭ xwC?^u 1 y'bHXqv_-
FCb #ZSYC)= u컮uT{dxVp7!;i ü9 R(ZdZLs f0'nڨ|]#wJFgyZXQ<4G |"l~~D yJB-Ԝ=s݈g! jտ)E[$7cUrpp`3 xF
xv
0g#s1Sd WOOZv~ NC *HOjʞy3)1Jz0**p^V
H-[i+jC9
E>;;yN
ٻY{^ş/"OOξvzCGzS( RK
5!a7`֑Z|&ԯToh1 NCv 0}_0Ԏ̋0ܽ3Z.akq.W8ڵ3
,10dTR#~ k 1n5\Ŕ00jjIU/߫ظ7-VJ}}?n)o0aH e!)28" cGW
ǐ34F=h⸊Ka׃7`bK
j)?Ő㘅i׆z2ח{PczLE-|oEĽLqg&O G%U"m9- *"^M0߱S V i"i* ć&H&"[m}WZ-Ts 6ЉŤqT] C2wL Z-My`y8)T
VFIQ&e-!L/}LXC"!+ j5\;R9;I2!;lvG$ ͑wk,P4IgQʥ$AIqvn 27B"Lk 7;PSk^8̺R>Ѿ<2x&>!C!+~L"jc!UG1ۖ)klrλƂJh@7t -rc&0lţHguR ~1"^̡jfY pT6 ^t$BmI8Z>qU$' MIQU> Ղihx5͂> 1lezlaYgCꪙt- fJ^#*9bi j]'/F/*[! jNq! D^>kgy.phKDɃOJ BqUJU.Sj1^C:5`> ѩa0ha1v0\WY ;\*0<]
/=4Z#.!u# #oM _/h Q9Kժ@T\ֺ=!,m] ¡ U͓'ψ-ˉz}y=LyTl'Pմi#IS046}xx BS-ް$Ip6tIcn÷Ш^
-Bu-pF" wa> a;0]#59Fmǐ6o8lK`XIљ&5 EhX5+
G~nti :❹ ӯ)7OAr^z _wyTCyf !WM= ť,0~BJ.m3̤Τnf0T 0,$~L-a4MҘд C 9NrR @穅mCE
S;7!QT'KÕe#27ai !Cw6lP4nxE+)bn»C>bXs~hIpJ3PP W_h֢:7Z(r4iF %ړU6n
C2$q>N|$)4Z%j'iRz!0eUiQ!_S-L-$iQ3xyaA%Q1Z3/*Y
>ŐEn8gJJ hEh: j: UC3qB؛kPgKzָW)Κ;p8s^iX\
H+,6 ;\ă>W9 owyفUq$d0F_@LcC2f|#.;Y y~$E $}j;Q
|@ <q}`(ǣ h $[S|d4k `n0*fJu vG\
(ODeWNRN,̌4 au04 ;xA\#6榇 N7YU Yiŏ
FSK3>!֬M R?etVTvrhf,tgY:%T0a
Cm*CE
fq&llȐ̕!?R0,cٵ샜pzf GKزqbM"$~G%TqÌ 2#g2Em,
CMWhŰa'ӈJefy0(nى(cJytƼ m:e~{T*Pۦa6l|Kj6%I2u qM^iJgLpg, ʼmB+:ź}ҷ@Ɵ;rS^b*)UoP I}qȴx^4jnpZbKLFZh =H=C}6S.Ip*@ c/Oudoh4&=Loh3{.PuWŰsGŰөCzGiEPx],a S&x
Ɔcm8|[Aϯ=2^HrRnʗvfuҽx;,Lǥ (GLʦKXHCBUF#* g ȜY?pC pGҲq
uq؛CpjY t
Өoʱ'w]]ONpp`ؾyN쒋'vvn C9*1B%r Q[7u
%j4*$R '0)t"#kAD&CVlz12!hY$<t#T9.|[t^!tmꁲ+6 eڴ4 Kt֫405z輗İŔN-];<*!> yQ"S NqI8##o1aa`͞`HO GtIY]Ǖkc$M0yKR%xhU a:}5\ŔM;+ȅFETf U;=J@ ˍOJyFn-8D Q*a| tl@ dLAKzހp0ğ:I#ݺP-]C ؓiԸ:6Q
z*I+(43j@
mQm>bd@8c>sp t
Uoe:iNBjtN} | {tu9c@clHQ{QXcBX[c5(k:Kє3Ba
N
˫ok"འP{-NNb|čLgAi1ͼ~o CϸB9OGz3`Ȇi[9,Țp|G"Q8qvR9 0ݦOʗG ڑqP}ma0q4\ #*1̔R1Ge(nS1-I=s: oQػyFkQ7ėKi
o<*R"5>*:,QzC)
!`]L9¨YL'jǝSf5{82 #oXScd laxpTY mbΗ*vUv-sT8U>o~|3ƅ\Q&[H4 } j^s<U1IƨT̖Oso^h yfOF@t8g87+#H?w$"I?n
2: = 4eط6C㹒HɢMtCMe8:WT1
F K>
efERHE:坙 /|_[;Ol?w nǃ_VGoef||#p߿tB㒺U!(s &&ULܸgh1Hw+-Ox47w+)-rxBSh:1\n0]nMu](~u8R6s% SJ!n j# =[ͮ ə~tұy68賦ԓT鋬ġn?vhKɱ0"hZ+0Դ'q< tvQx'HS?)b+0xmk)[!< oэ82]ɑ.yi'ǩ L;"IsA1*ް9QCG"6H
?)Mlr33hM:|)Y~7xW?Es}Tj VBRi L ? Ψ mveؘA0BٗJibMS 6!*
+h4̛;Dz 6ɻ[MIFǂ β x( a{;L
x:x whBO G_mH;
t> . յ #yhx 6
t
&8QfC#R wf`PsD4= C&uqgv ZDᓼ,|zx=!Tq F:
VoBtt'q0cOi173^;Rj@ ¨z=5|*M 1C+rx"Ë4+\aJqq Ѩ"}eߞ0|jpxPtd(>
B#LM\ YjHnj
*SiuCŢ2F Vpe<~[e{lώjIt1Fa7i(VK"UnN )9!l0fµ, YVx 75Ba)4CbkK1\LE? v* ~忒xTU^_XL. K}jg-_hjz, fH ) Κ) 4viL1'qv: ax{6ɘD5ihTjg,OoH HBNbX'\Q|V4CR۔ pKat:I8 6E9jCA8\=o4vE2 5lR *K*=IʥUΣgF[4Ym}[W 8ve!0l &=L27aL'&F)aH |-
nJ]*o3 =!alid
Gs6Rq:,QD
Tq2,'_zι
ZÃe
nuR1t^Vcx8p= 4$+u<w!ff0?pG;{j'wReVTF3)ҜWl;,UᱞbgV$3ssK~p& %-7DЌ5i)>_> zh'#,m )Y01^XTƊ
yNs{Q~C.[PPX7)(
J[|@} x4]=:!=@GVDvqlN1tgN䑔Y2
̯%!x5挢 60\"-$z̻0 ]
Þ a5j z1 P- <쫘zppnxTh~XTI\AlGu&^PQJp6 khd! d {-KXadsnzpStjt{~zyiLZn@x5 {k>3OM*my˩,SF(3Nb[ iz\p!Z9L(}\%6?eo(gyI QX7dQD #
"1e
geXI2d$O7Ɣ T x n7
_xB>ƆU2k5j0H0bi3囉"oԃ %!wҧZ@XdfWp Ea.AO^+Je2lXdi5*X[(D9DC:^|@ a_d>`bOmhKyO0Y|izUvF(
eŧC!5)}ii OEA&px
Ʈ=U CF$IB܍C!fuҹwv'AƐ 6nWt5ī1Y~g 1pŜb"P\+F!5K/YdŒ Q,B:R]7҄b4̣&1q ayc.%3y T /ӓRQaXVTV$}V]䰏,C-ʠ l#؊!D+.IaU.अ&70s PXoRV(ΐ?H4̢"
z^O'Z%a_P/[}rXL"*wM ;q5lD 0C0S
bݺ'$
D".b1X2|Q/h_TA4#>o
31f v=/]rQ AؔT (QG,|G 1F}Nh+5EfFax#0 uMZ YC}DAUKL )!h GTz1j
{aXYʃϻHLOw"0Ԙ 2Vt%iy*Gq@YKZBUĐzql`?[wUS5EAh̐Jܑ, ĔU ej
lk3]>0Y[oa[hf("
M6^4Rk+'X0#1&!df6&*4(9L.GЁ(aak̀W)MkO,P0 V}%*l" ѯۯx(2C0"Ez0aEyE{Ě 2ܳ' C&t* WoCZsOT0+m^ 41I¨HI yL*qEe: aїnJp-h~}z8.\n2B%b=wx Pnqh&ҝ!CKtFrI#5#/ 9ԏT1(?ŋɢf/F̫VdTHzA V _G~t_(l{p 3_}WM жi4a=a
@WTڵ =08jӔT%0ëv1nSn`ǰ6(PP6bV:/P^jY3;^Oe $1-;q&J?Hm+Js_*1x>: z\ z(I|Jઈ WK,q.Wt[n
>u _iigC)m ;> k?#WȾ)&̌qU M t /جP\nyAnMٜFU!
3 7H\95yLp5=+,ѧ a"_#bE&.6n (;ZO@ReF bԇGIxwɢH+@OȠŰCVY2؉ļEYi=ҷY uщB7&
11J q^C㎘9?t/t
4 Űc=4x*qzqQ, L>
\T/EUȟ&mAݫ0LgLHE#, (6ؖIx4iG4R;ocb8!?CDjИ
C7@ !oVr [
Y(Y#'n41|nUa[(u
o&\^RD `v5 /Sx8Vi$# >o 𫪸"ka ×ޚ1hQG^(>z OV>?B%rlN^p D=/s KP
l,L 3m/İ3 t5h1<՞V 賠]MlGpRLz̜Pu^ ZZ
ÍJZfdVaؔXKZ%%:n\A\ưi3i/lUAwdEc\{, , d|j^aB ys#Ť Y| ޟaX5Cןȿɵˋ4{kT&-ow+Z=S'ؓ;!=a8 ^C-<韆=wɍd?°
U (梷ii1xv)c3س^V^0O6q;& 9GNyF}1XMi
I: 3z Z R6WO% __;|4D]jig L:6-Y0Qk
G&=a [j+32aI C=del<('.5c6,6l & #gǚ[ mxjtҌ=64
v\tІWbx4I
~ _Pٰq6-l{`x= `Æn
ڰ1 _OjƫgÆІ
6lذaÆ
6lذaÆ
6lذaÆ
6lذaÆ
6lذa? P
endstream
endobj
38 0 obj
<>/Font<>>>/Fields[ 44 0 R 40 0 R 43 0 R 45 0 R ]>>
endobj
39 0 obj
[ 40 0 R 43 0 R 44 0 R 45 0 R ]
endobj
40 0 obj
<>/DA(/Helv 12 Tf 0 g)/F 4/FT/Tx/MK<<>>/P 14 0 R /Rect[ 175.951 714.99 490.173 736.99]/Subtype/Widget/T(Category)/TU(Category you are nominating your preceptor for.)/Type/Annot/V(Outstanding MSTP Preceptor)>>
endobj
41 0 obj
<>
endobj
42 0 obj
<>
endobj
43 0 obj
<>/DA(/Helv 12 Tf 0 g)/F 4/FT/Tx/MK<<>>/P 14 0 R /Rect[ 210.763 676.182 490.799 698.182]/Subtype/Widget/T(Preceptor Name)/TU(Preceptor Name. Please enter as Dr. FirstName LastNmae \(i.e Dr. Kristin Furfari\).)/Type/Annot/V(Dr. Daniel A. Pollyea)>>
endobj
44 0 obj
<>/F 4/FT/Tx/Ff 8392704/MK<<>>/P 14 0 R /Rect[ 62.8364 125.927 540.982 666.909]/Subtype/Widget/T(Reason for Nomination)/Type/Annot/V(\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n)>>
endobj
45 0 obj
<>/DA(/Helv 12 Tf 0 g)/F 4/FT/Tx/MK<<>>/P 14 0 R /Rect[ 141.382 93.9273 463.6 118.836]/Subtype/Widget/T(Student Name)/TU(Your Name and Phase. Please format as FirstName LastName, Phase IV \(Tracy Johnson, Phase I\))/Type/Annot/V(Anagha Inguva Sheth)>>
endobj
46 0 obj
[/ICCBased 21 0 R ]
endobj
47 0 obj
[/Indexed 46 0 R 100 22 0 R ]
endobj
48 0 obj
[/Indexed 46 0 R 108 23 0 R ]
endobj
49 0 obj
[/Indexed 46 0 R 138 24 0 R ]
endobj
50 0 obj
[/Indexed 46 0 R 148 25 0 R ]
endobj
51 0 obj
[/Indexed 46 0 R 150 26 0 R ]
endobj
52 0 obj
<>
endobj
58 0 obj
<>
endobj
59 0 obj
<>
endobj
60 0 obj
<>
endobj
61 0 obj
<>
endobj
77 0 obj
<>
endobj
78 0 obj
<>stream
HMoA +| 2= TH@CUU% mE~=$F{ymۇ.j3V&7S6Ũ'pGOoF홎i
)'k* EJ$}C;znO>"h*)CelbX7B I}ىh4Imj~wUE D)k[I 0qyl1F .
%ݺv4
@#V~uy,ɍEvu9{' w
endstream
endobj
79 0 obj
[ 81 0 R ]
endobj
80 0 obj
<>stream
H\j0 ~
Cqa rV [I
m琷&G'~Is]y`ZL;o 0App^XgCߌ:
pL A5onNؽ^/H={
G
P
,>
endobj
82 0 obj
<>
endobj
83 0 obj
<>
endobj
84 0 obj
<>stream
Hj``0
endstream
endobj
85 0 obj
<>stream
HV{PT ` ,T+R%U bjcLtiL ;㌱d48Lh#h w.$c2Sg{w9s/ DHy[Z \ %k4e=5g"!ށAo@Op/YL{Dr}P)O 77S!!
C]ޗ&^E b;688JK--Ò+ *>byL VI?vc밣g^*䢲ԺhF", +55j y:v^uZ\|7ޕ%+L(z\XWL2kR/JR\
-jRL
q'- kwlf2+{0=/
_+w:6GRu@;w{P-Cw:˞]`''ʗfd5Hӛo)@n{{u ekvf7Uo,δ<^4oxJ< i.n1E@μȨnHov^\%x0.t'}R ^ /bBY ܚRH0bXfM\),S~!Qo Jk3]͙9E9 ZLcict[j_[`Catf:w`ڬSGaw>ݵպڦڰ-%- żږح='p)'ӻT갭>z?8T z%ݰ~| gi~Mzb
Z!~ݚ\Qb6PߡVBb=BNY\x5@*"-LVI7 Ӕ$n wfwtΛF ț ɉc\-iop~1>
Ng߄xK ۅiJ!Ns);U8C^+mX:#1ZKܮ%- =aW0O.xM@|CGZu$ߢ2`b
qם==3I# 5Mƞ<_uc ƫwXEr l -_ٯCV)9`DK0|Яgh lxy yMhM4;FReT)1}+gA $.de 3+ 9qa4A,W\W*2\9@ y| #PBV: Bߟȑ(Ǖ i? g¼ ߪW)HQn\(]2
"0/
aDO x|+8_k
|#CZEV{ޑ,!ԝUyCވ3~s`?48Q6C#C=!r(8Zт_pם[Y ,u9-
xP ch|#/uj
i1kԇ UP jC[/|mnWB &o>FX1dO*1r
¯9n|F,u 4 {?m1b ~##|"څFN ^ڢF?GF;V颖֙6&L~"xkɷejVFV H*6USj&V5Ajoqp0q0p0xo8[F
NCv20 h溁#EHlp`䚱! 6((l`C|%eb 0 'w
endstream
endobj
88 0 obj
<>>>stream
x
endstream
endobj
89 0 obj
<>
endobj
90 0 obj
<>/Subtype/Form/Type/XObject>>stream
x+
Ppu*r
2PH2T0ӳ060UIH)S04RI/-).IKKW
P(JMN-(/Tr
4
endstream
endobj
91 0 obj
<>>>stream
x
endstream
endobj
92 0 obj
<>
endobj
93 0 obj
<>/Subtype/Form/Type/XObject>>stream
x+
Ppu*r
2PH2T0ӳ060UIH)S04RIp)SpILQpSɩLMTr
4 Rv
endstream
endobj
94 0 obj
<>>>stream
x
endstream
endobj
95 0 obj
<>
endobj
96 0 obj
<>/Subtype/Form/Type/XObject>>stream
x+
Ppu*r
2PH2T05437PI
[p
. !
endstream
endobj
97 0 obj
<>>>stream
x
endstream
endobj
98 0 obj
<>
endobj
99 0 obj
<>/Subtype/Form/Type/XObject>>stream
x+
Ppu*r
2PH2T34060TIH)S04RIpKLHTK/-KTH-Tr
4 6E
endstream
endobj
100 0 obj
<>
endobj
101 0 obj
<>/FontDescriptor 102 0 R /Subtype/CIDFontType2/Type/Font/W[ 7716 7716 250 814[ 219 406 667 448 823 729 177 292 292 427 667 219 313 219 500 469 469 469 469 469 469 469 469 469 469 219 219 667 667 667 365 917 693 638 636 775 670 585 770 812 354 334 748 598 952 787 769 589 761 714 463 631 723 699 911 713 682 635 271 500 271 500 512 333 493 517 405 519 424 357 425 531 270 248 517 270 778 530 484 519 519 376 359 342 528 474 667 452 459 398 479 500 479 667]]>>
endobj
102 0 obj
<>
endobj
103 0 obj
<>
endobj
104 0 obj
<>/FontDescriptor 105 0 R /Subtype/CIDFontType2/Type/Font/W[ 7716 7716 250 814[ 219 406 667 448 823 729 177 292 292 427 667 219 313 219 500 469 469 469 469 469 469 469 469 469 469 219 219 667 667 667 365 917 693 638 636 775 670 585 770 812 354 334 748 598 952 787 769 589 761 714 463 631 723 699 911 713 682 635 271 500 271 500 512 333 493 517 405 519 424 357 425 531 270 248 517 270 778 530 484 519 519 376 359 342 528 474 667 452 459 398 479 500 479 667]]>>
endobj
105 0 obj
<>
endobj
106 0 obj
<>
endobj
107 0 obj
<>/FontDescriptor 108 0 R /Subtype/CIDFontType2/Type/Font/W[ 7716 7716 250 814[ 219 406 667 448 823 729 177 292 292 427 667 219 313 219 500 469 469 469 469 469 469 469 469 469 469 219 219 667 667 667 365 917 693 638 636 775 670 585 770 812 354 334 748 598 952 787 769 589 761 714 463 631 723 699 911 713 682 635 271 500 271 500 512 333 493 517 405 519 424 357 425 531 270 248 517 270 778 530 484 519 519 376 359 342 528 474 667 452 459 398 479 500 479 667]]>>
endobj
108 0 obj
<>
endobj
109 0 obj
<>
endobj
110 0 obj
<>/FontDescriptor 111 0 R /Subtype/CIDFontType2/Type/Font/W[ 7716 7716 250 814[ 219 406 667 448 823 729 177 292 292 427 667 219 313 219 500 469 469 469 469 469 469 469 469 469 469 219 219 667 667 667 365 917 693 638 636 775 670 585 770 812 354 334 748 598 952 787 769 589 761 714 463 631 723 699 911 713 682 635 271 500 271 500 512 333 493 517 405 519 424 357 425 531 270 248 517 270 778 530 484 519 519 376 359 342 528 474 667 452 459 398 479 500 479 667]]>>
endobj
111 0 obj
<>
endobj
112 0 obj
<>
endobj
113 0 obj
<>/FontDescriptor 114 0 R /Subtype/CIDFontType2/Type/Font/W[ 7716 7716 250 814[ 219 406 667 448 823 729 177 292 292 427 667 219 313 219 500 469 469 469 469 469 469 469 469 469 469 219 219 667 667 667 365 917 693 638 636 775 670 585 770 812 354 334 748 598 952 787 769 589 761 714 463 631 723 699 911 713 682 635 271 500 271 500 512 333 493 517 405 519 424 357 425 531 270 248 517 270 778 530 484 519 519 376 359 342 528 474 667 452 459 398 479 500 479 667]]>>
endobj
114 0 obj
<>
endobj
115 0 obj
<>
endobj
116 0 obj
<>/FontDescriptor 117 0 R /Subtype/CIDFontType2/Type/Font/W[ 7716 7716 250 814[ 219 406 667 448 823 729 177 292 292 427 667 219 313 219 500 469 469 469 469 469 469 469 469 469 469 219 219 667 667 667 365 917 693 638 636 775 670 585 770 812 354 334 748 598 952 787 769 589 761 714 463 631 723 699 911 713 682 635 271 500 271 500 512 333 493 517 405 519 424 357 425 531 270 248 517 270 778 530 484 519 519 376 359 342 528 474 667 452 459 398 479 500 479 667]]>>
endobj
117 0 obj
<>
endobj
xref
0 1
0000000000 65535 f
3 1
0000000017 00000 n
6 6
0000003765 00000 n
0000004057 00000 n
0000004136 00000 n
0000004175 00000 n
0000004202 00000 n
0000004260 00000 n
13 2
0000004511 00000 n
0000004613 00000 n
21 6
0000005038 00000 n
0000007733 00000 n
0000007993 00000 n
0000008255 00000 n
0000008572 00000 n
0000008908 00000 n
30 7
0000009253 00000 n
0000015063 00000 n
0000021567 00000 n
0000032679 00000 n
0000042967 00000 n
0000056688 00000 n
0000078666 00000 n
38 15
0000098013 00000 n
0000098175 00000 n
0000098229 00000 n
0000098474 00000 n
0000098568 00000 n
0000099764 00000 n
0000100049 00000 n
0000100254 00000 n
0000100543 00000 n
0000100582 00000 n
0000100632 00000 n
0000100682 00000 n
0000100732 00000 n
0000100782 00000 n
0000100832 00000 n
58 4
0000100912 00000 n
0000101183 00000 n
0000101563 00000 n
0000101791 00000 n
77 9
0000102142 00000 n
0000102280 00000 n
0000102852 00000 n
0000102882 00000 n
0000103191 00000 n
0000104512 00000 n
0000104584 00000 n
0000104867 00000 n
0000104952 00000 n
88 30
0000107390 00000 n
0000107496 00000 n
0000107533 00000 n
0000107807 00000 n
0000107913 00000 n
0000107950 00000 n
0000108219 00000 n
0000108325 00000 n
0000108375 00000 n
0000108623 00000 n
0000108729 00000 n
0000108766 00000 n
0000109038 00000 n
0000109151 00000 n
0000109710 00000 n
0000109858 00000 n
0000109971 00000 n
0000110530 00000 n
0000110678 00000 n
0000110791 00000 n
0000111350 00000 n
0000111498 00000 n
0000111611 00000 n
0000112170 00000 n
0000112318 00000 n
0000112431 00000 n
0000112990 00000 n
0000113138 00000 n
0000113251 00000 n
0000113810 00000 n
trailer
<<808236ED0459C4A534EEA14AF5FDEA92>]>>
startxref
113958
%%EOF
3 0 obj
<>stream
Acrobat Distiller 17.0 (Windows)
PScript5.dll Version 5.2.2
2023-07-07T16:47:48-06:00
2021-02-08T17:08:04-07:00
2023-07-07T16:47:48-06:00
application/pdf
Microsoft Word - SAMPLE nomination letter template
paradisv
uuid:16daf5bc-e061-4c56-9f67-a505fca21083
uuid:80b37e28-b0e5-104b-a06c-a65c37acb105
1
1.1
endstream
endobj
11 0 obj
<>
endobj
44 0 obj
<>/F 4/FT/Tx/Ff 8392704/MK<<>>/P 14 0 R/Rect[62.8364 125.927 540.982 666.909]/Subtype/Widget/T(Reason for Nomination)/Type/Annot/V(To the Golden Stethoscope Nomination Committee, \r\rMy name is Anagha Inguva Sheth and as an MD/PhD student, I have been on the CU Anschutz campus for 7 years thus far. During this entire time, Dr. Pollyea has been my Foundations of Doctoring preceptor. S\
imply put, Dr. Pollyea is the best clinical mentor I have ever had in my career during both medical school and graduate school. Therefore, I am nominating him for the Outstanding MSTP Preceptor award. \r\rI requested to work with Dr. Pollyea during the fi\
rst year of medical school as I wanted to be able to focus my thesis work on a clinically relevant scientific question. Dr. Pollyea immediately fostered my love of bench to bedside research by allowing me to see complex acute myeloid leukemia \(AML\) pati\
ents with him. Dr. Pollyea is one of the worlds leading experts in AML and specifically the most novel clinical trials being performed. He pioneered the advent of venetoclax based regimens in AML which have significantly improved the outcomes of elderly \
patients. I was lucky enough to be working closely with Dr. Pollyea while these clinical breakthroughs were being made during my first two years of medical school. His research has revolutionized AML patient care and he is the epitome of a clinician-scien\
tist. Furthermore, working with Dr. Pollyea gave me the unique experience of being able to frame my scientific findings during graduate school in the context of patient care. \r\rAlthough I was seeing a specialized patient population, he made sure I was \
gaining the basic skills required in all aspects of clinical medicine. At every phase of my training, Dr. Pollyea was thoughtful about creating the best learning environment for me. Early on, he spent the majority of his time teaching me the basic skills \
of clinical medicine while I worked alongside him. As I continued to gain experience, he allowed me to see patients independently and report back to him with a plan that I thought was best. Additionally, Dr. Pollyea taught me how to be the best physician \
possible to patients during some of the most tumultuous moments of their lives. His thoughtful approach to my learning is what has allowed me to succeed in clinical medicine thus far. This approach has also given me the opportunity to have longitudinal ca\
re with patients and their families-some of whom I have known for 7 years. This is only possible due to Dr. Pollyeas enthusiasm for mentoring and his dedication to my learning. \r\rDr. Pollyea is an extraordinary clinician-scientist who I look up to as a\
mentor and role-model. He consistently uses evidence-based medicine and careful evaluation of clinical trial data to guide his practice. This is a key skill that he has taught me over the years. Additionally, he has always been involved with the scientif\
ic work in the Jordan lab, where I completed my PhD, to ensure we can work on novel therapeutic strategies for AML patients. His dedication to both scientific inquiry and patient care was critical to my thesis work, preceptorship, and career goals. Despit\
e his busy schedule, he has always been involved in my thesis work and help me develop the best experiments that can be translated to AML patient care. This has resulted in the development of a clinical trial for AML patients based on my graduate school r\
esearch. This incredible opportunity is a physician scientists dream and is a direct result of Dr. Pollyeas mentorship. \r\rIn closing, Dr. Pollyea is an amazing clinician-scientist who has a breadth of knowledge in both clinical medicine and research, \
which he seamlessly integrates. He is a role model of who I aspire to be as a physician-scientist. He has consistently taught me how to integrate scientific research into clinical practice. I cannot think of anyone more qualified or deserving of the Outst\
anding MSTP Preceptor award. )>>
endobj
118 0 obj
<>/ProcSet[/PDF/Text]>>/Subtype/Form/Type/XObject>>stream
HWIs:W8Se!ܗc^2o2UTSs`$p_Cf7@E/[淯6?/MILImҸemzuⷫ_Tsrsusln/M"*oWf a"2c槙(b~OTx". ϯ6l>iu'GmWXɴ G.70/EDmx (X<@!FE2_v!*D@a-c'ok9,ubf
iη"
vKeo")_A÷Ax
>^Ρ"O)ƹ"|jyGxɵE)t}~j@0IQ?xTv?oT ݘY!3zP/MihBQRL7j\-^ws
#[h,
r(!V]R}>
c6L@\`0]jLЖPf~%gSU!Da^UjǂZ8Ytn̓C]p:, O~02J6.h8pq"(#H >& uҩl++7 37>ڲQހi-ֳ/ɓ :$7(< \ժWjGR$\lvL`i$":uK:Z牄 N0B~WߨbpQ;x:{IjSn$ * Q}0 MGSJt4 tokz{DKQeu D(;*+lF nmhS9A,4$ u NXm2p" "gHܸ5 qFj~+i͙ wnmہd04yLu,ԸR*6z'Ouza5ًkU5
{dST(t `&SfH!QZ_l8¿2;VD1#QӝjNӷi't#X쁽aTH&ɱ6]P ~09x(6 Q`bhtG^T ~)^U)1/VSh
dQrjf(%{-EdQ9X(5^xAcM`̩@6I%wEmlj4U#)0ƀ@Cna @m}=) 2goSMNز{h F
}قfzZ=
a 3VQ8nXCQn3o^/VJ F}3(oqEn
ZbiV9n^AuX,s!(t%V]<
98 E!|!J
+nxBBWګi&k|,!5 }v{nyif5GѴθck}Fjmgk8s XX)ߧ [ fpqJ{b~ny[s=!z%CV QutϢpռ~tĽ~sn{$ZH0y7Ϭh% li#3.Va Yb3 aB < g v
eu.0+ADDܛl =|r{ii
`Jg}8zu(1|sG?ʕѲ/n%ܲɪi"'5]ȧ 3Ͷ-)Zı1峦42+Q)ǁ擳կt7Ѣyʪe@=N3:əbb..*}i]W7^3VϺ]f7#" aV#r>b&Y ,6LUd
=KI=A"-_JOh0 oaL2Q櫅c!lL`,,`6`=NxbeShTLB*E sxn @tՇ kӒp%LAu86?1 i
XP4 J6axeVy7)L(
co * Mʗ }7G@t/L,"bՏҢ `)) (X<{ڳE](M~fȩ *-`ig膙Ƙ;Ӟ3\]b+~sig,iԶ5;⠘ >fv (4(9u
' W>˓$ mRLfk|n6>Q>gi~љh߲v8e uuI 1rC@Y`^fALYYe>/-o^6G0T8{V D@9c%㌎tyBy4 {~El >f̴fNsEa%"n8IkjjX} 1H/+ɰ>? erJlf.Z:Cm! ezWW\K~/ MҡTM2e |4&J:Q#UHRgeaCJmi "ǯGzF82y yzh[I +}}p b8^xX w :]nNhx
t D 37nL֤MQ+Z)<ܷ>+M3FL& )Ӄ ,v/}a
#~{*I<ە3t:
#2MJqqOY3 :Rdf\3!E"$3:dWɦm
,jS/I R'U_MF[8 MK; Ld|]O"X. ,2H & y<3tf{n[ckzϴm@ Q duyO1xM`qĥ{ .m
].E:^ &qS/#_s 9vHJ$}ڦ%A*#ɦFE^|hǏ7 P4
endstream
endobj
xref
0 1
0000000000 65535 f
3 1
0000115792 00000 n
11 1
0000119537 00000 n
44 1
0000119785 00000 n
118 1
0000123837 00000 n
trailer
<]/Prev 113958>>
startxref
127874
%%EOF
3 0 obj
<>stream
Acrobat Distiller 17.0 (Windows)
PScript5.dll Version 5.2.2
2023-07-07T16:51:26-06:00
2021-02-08T17:08:04-07:00
2023-07-07T16:51:26-06:00
application/pdf
Microsoft Word - SAMPLE nomination letter template
paradisv
uuid:16daf5bc-e061-4c56-9f67-a505fca21083
uuid:8903e22f-215a-a843-985b-0c80eacb6448
1
1.1
endstream
endobj
11 0 obj
<>
endobj
44 0 obj
<>/F 4/FT/Tx/Ff 8392704/MK<<>>/P 14 0 R/Rect[62.8364 125.927 540.982 666.909]/Subtype/Widget/T(Reason for Nomination)/Type/Annot/V(To the Golden Stethoscope Nomination Committee, \r\rMy name is Anagha Inguva Sheth and as an MD/PhD student who matriculated in 2016, I have been on the CU Anschutz campus for 7 years thus far. During this entire time, Dr. Pollyea has been my Foundations \
of Doctoring preceptor. Simply put, Dr. Pollyea is the best clinical mentor I have ever had in my career during both medical school and graduate school. Therefore, I am nominating him for the Outstanding MSTP Preceptor award. \r\rI requested to work with \
Dr. Pollyea during the first year of medical school as I wanted to be able to focus my thesis work on a clinically relevant scientific question. Dr. Pollyea immediately fostered my love of bench to bedside research by allowing me to see complex acute myel\
oid leukemia \(AML\) patients with him. Dr. Pollyea is one of the worlds leading experts in AML and specifically the most novel clinical trials being performed. He pioneered the advent of venetoclax based regimens in AML which have significantly improved\
the outcomes of elderly patients. I was lucky enough to be working closely with Dr. Pollyea while these clinical breakthroughs were being made during my first two years of medical school. His research has revolutionized AML patient care and he is the epi\
tome of a clinician-scientist. Furthermore, working with Dr. Pollyea gave me the unique experience of being able to frame my scientific findings during graduate school in the context of patient care. \r\rAlthough I was seeing a specialized patient popula\
tion, he made sure I was gaining the basic skills required in all aspects of clinical medicine. At every phase of my training, Dr. Pollyea was thoughtful about creating the best learning environment for me. Early on, he spent the majority of his time teac\
hing me the basic skills of clinical medicine while I worked alongside him. As I continued to gain experience, he allowed me to see patients independently and report back to him with a plan that I thought was best. Additionally, Dr. Pollyea taught me how \
to be the best physician possible to patients during some of the most tumultuous moments of their lives. His thoughtful approach to my learning is what has allowed me to succeed in clinical medicine thus far. This approach has also given me the opportunit\
y to have longitudinal care with patients and their families-some of whom I have known for 7 years. This is only possible due to Dr. Pollyeas enthusiasm for mentoring and his dedication to my learning. \r\rDr. Pollyea is an extraordinary clinician-scient\
ist who I look up to as a mentor and role-model. He consistently uses evidence-based medicine and careful evaluation of clinical trial data to guide his practice. This is a key skill that he has taught me over the years. Additionally, he has always been i\
nvolved with the scientific work in the Jordan lab, where I completed my PhD, to ensure we can work on novel therapeutic strategies for AML patients. His dedication to both scientific inquiry and patient care was critical to my thesis work, preceptorship,\
and career goals. Despite his busy schedule, he has always been involved in my thesis work and help me develop the best experiments that can be translated to AML patient care. This has resulted in the development of a clinical trial for AML patients base\
d on my graduate school research. This incredible opportunity is a physician scientists dream and is a direct result of Dr. Pollyeas mentorship. \r\rIn closing, Dr. Pollyea is an amazing clinician-scientist who has a breadth of knowledge in both clinica\
l medicine and research, which he seamlessly integrates. He is a role model of who I aspire to be as a physician-scientist. He has consistently taught me how to integrate scientific research into clinical practice. I cannot think of anyone more qualified \
or deserving of the Outstanding MSTP Preceptor award. )>>
endobj
119 0 obj
<>/ProcSet[/PDF/Text]>>/Subtype/Form/Type/XObject>>stream
HWKoW14m GV/-5 1#OqUݔj|@]U߫>>f(ؠ?>_ٞӹ~w~KhH}Q_sw"~ <J&xǦsNwHi>ϡ*{8ףlS,a]U) m kܙi!f+D ڣK:d@QQ!Dn:HJ/E[_t1/_0
. 2LcʼnHC#p"-f.Db,nU[TrOQT6= OX}d@
1GK/(&pb+#
F )]bDU_QFc]jW4i/>~m{Pq ~>%NꞖ w f+imݱbī P.9YV:
? NsͩO{UL䎡iZBc((Y Vj0E- B~= 6{zXi 3(;_ȠyCM[i[6 z,2 6T>0U]٧ r|2 cq?
-*5:q zr6rˌ_`5R@.6?+ 피 nj$u vyy)K__JG9MٰgJ~W:dv/dGSÂ ʕv`q
>/$W R|3i{ y84 3\`\(豽#ls4쇹,Tc&pﴛO/bێWP>Z [
9qϡrZRWyoo(:XrZ,\
wb q2 %8i;]'Qbz}ƚ!08lU֙%6 :ِ[x *0P]Zj@n|Da)j QۛXI- U ЫI&Å xi帿1QK`b 4pX%vh
[+{2"*8r> $aqmn618yV7vgF wcMϬAp`Z^@>,B E 0s] Cm3mCL3'AdTlprb<;enEY1_X䟦#eο"wA7BdQQ@=u4d.v2jnh XRFA fڀiT4G} {6''HVx)b2o*zh
w
h9Rթ 3w',&"gSlKP/B![lCz [Yd5hkc"#cZr *ifM_WIЄv) ROFc|ѧMt9fP#5#\-'xo}؟+ 317}) Oo
8/,=>//'b*ϕalz; 4Py}tgsm> *~i]w30VϦ_f7#lb:ҬB,}¶JY BD{"Jlz|M
};IM C!/_L.7 w TDjX
cKdL,XedMg8Y FX<1 *$#"rAW[%>FZ[`d~Îi-oq l a5}nb 7bhZmxV b#Kao9|8[#(6HXJ'8d`N `S4D?D_4Գ9obFK3a_srs!+](l%ϝ'?&z|!ZmSZ_d9.H=4ʼn 1A6êl 귰Ac× `I27K}>6tOA rU_tFڷEBOă8 2Dv:Y P:'E+*P>:Pq7psP96a 8NLi "jbp~} {!v^mݳ´U1+H\Q(Pn"(]1
{'=|/ @r ӿ .
.ffoe&39^we!8͵9xf$ JU(ízoX pʷNc ;RE,$ul3;Ii
!R [NL G|^7tozns#di߂+jg Sh-c`^
"]{;ۮd"KR: W*Ck]hVSlP;YycPN/:7m}`4N2~Ac#^paٰ[51ʂ,K]? (kzeSI)PS
F8o)|gIPGqʓՆ a6r`%z5Tp#u[XjB~2;Թwpi1z=5VN=2,ZGH -q^ks $3013T# HVI ]CP -*7ׯ ;mL+)v piIiNo̺ NduoFix
rx FO8/!)tCB`9 G kèECň_boO40iweDǸ!ptWp)Qz_t#= N`7KCfPG
Wڌkvf7 6SDF2CvV`Ȣv>!6~\Ti GxA`# ,Ox ZxKe_zq4\B0s8"4Orٝ¬BnwlZLֱ *> =gu)7F|-NDB^rKB)x M+.NA ˎ"`$b`ukN0p~dpJm^,#-&9@ۦn*p xhE|4QQUڷç Ќ
endstream
endobj
xref
0 1
0000000000 65535 f
3 1
0000128163 00000 n
11 1
0000131908 00000 n
44 1
0000132156 00000 n
119 1
0000136233 00000 n
trailer
<<7A4C8C0526134487A2D7F3F84EFD852C>]/Prev 127874>>
startxref
140314
%%EOF